Advances in quantifying circulatory microRNA for early disease detection

Area of Science:

• Biomedical Diagnostics
• Molecular Biology
• Preventive Medicine

Background:

• Precision preventive healthcare integrates early detection and intervention for improved patient outcomes.
• Clinical adoption of novel assays is crucial for effective preventive healthcare delivery.
• MicroRNA (miRNA) biomarkers from liquid biopsies show promise for early disease detection.

Purpose of the Study:

• To review the clinical utility and validation of miRNA-based molecular diagnostics.
• To discuss considerations for developing multi-analyte clinical assays.
• To highlight advances in PCR-free miRNA detection for point-of-care testing.

Main Methods:

• Review of large-cohort studies on miRNA biomarker validation.
• Analysis of clinical utility and development considerations for miRNA assays.
• Examination of recent progress in integrated PCR-free miRNA detection systems.

Main Results:

• miRNA-based assays are advancing towards clinical practice after rigorous validation.
• Development of multi-analyte assays requires careful consideration of various factors.
• Progress in PCR-free systems facilitates point-of-care miRNA detection.

Conclusions:

• miRNA diagnostics hold significant potential for early disease detection in precision preventive healthcare.
• Further validation and development of assays, including point-of-care technologies, are essential for clinical integration.
• The field is moving towards more accessible and efficient miRNA-based diagnostic tools.